ADIPOQ and chronic kidney disease: Adiponectin, secreted from adipose tissue, has been reported to possess anti-inflammatory and anti-atherosclerotic actions in the healthy organism; however, in CKD, it is often elevated, and used as a biomarker of progression of CKD and a predictor of mortality [35].